Roche's Passage To India: Repetitive Patent Hearings, Uncertain Rulings
This article was originally published in PharmAsia News
Executive Summary
Patent litigation is always uncertain, but in India pharma companies confront unusual hurdles: separate proceedings when a patent is challenged by numerous opponents; conflicting rulings; a 10-year review backlog; and a law limiting the patenting of new formulations